市場調查報告書
商品編碼
936508

先天性代謝異常醫療食品全球市場:產業趨勢和至2027年的預測

Global Medical Foods for Inborn Errors of Metabolism Market - Industry Trends and Forecast to 2027

出版日期: | 出版商: Data Bridge Market Research Private Limited | 英文 374 Pages | 商品交期: 3-5個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球先天性代謝異常醫療食品市場在2020年∼2027年的預測期間將以12.3%的年複合成長率成長。新的市場報告,包含2018年的成果資料,計算的基準年是2019年,預測期間從2020年到2027年

促進全球先天性代謝異常醫療食品市場成長的主要原因

先天性代謝異常的發生率增加

比起酵素補充療法更偏好營養補充品

為了提高IEM相關意識的政府配合措施與計劃

目錄

第1章 簡介

第2章 市場細分化

第3章 摘要整理

第4章 重要考察

  • 臨床試驗
  • 最新趨勢
  • 品牌的競爭力分析
  • 供應鏈分析

第5章 市場概要

  • 促進因素
    • 先天性代謝異常的發生率增加
    • 比起酵素補充療法更偏好營養補充品
    • 為了提高IEM相關意識的政府配合措施與計劃
    • 新生兒篩檢法的增加
  • 阻礙因素
    • 不完全的償付方案
    • 醫療食品的嚴格法規
    • 醫療費高
  • 市場機會
    • 新適應症的創新產品的銷售
    • 醫療食品產品的支出增加
  • 課題
    • 產品的回收
    • 醫療食品取得難做

第6章 COVID-19的影響分析

第7章 各產品市場

  • 概要
  • 氨基酸
    • 單一氨基酸
    • 氨基酸混合物
  • 低蛋白質食品
  • 含有鐵的GMP氨基酸修飾嬰兒用製劑的速激肽
  • 低鈣/無維他命D的嬰兒用配方
  • 其他

第8章 各年齡族群市場

  • 概要
  • 嬰兒
  • 斷奶期
  • 青年時期
  • 成人

第9章 各疾病市場

  • 概要
  • 苯酮尿症(PKU)
    • PHENYLADE
    • PERIFLEX
    • LOPHLEX
    • 其他
  • 酪胺酸血症的類型I及II
  • 械槭糖漿尿症(MSUD)
    • ANAMIX
    • COOLER
    • MSUD GEL
    • AMINO ACID BLEND
    • MAXMUM
    • 其他
  • 均質胱胺酸尿症
  • GLUTARIC ACIDEMIAI型
  • 尿素循環障礙
  • 甲基丙二酸血症
  • 異戊酸血症
  • 有機酸尿症
  • 腎臟疾病
  • 丙酸血症
  • 白氨酸代謝的障礙
  • 其他

第10章 各形態市場

  • 概要
  • 粉末
  • 液體
  • 其他

第11章 各包裝型態市場

  • 概要
  • 罐頭
  • 箱子
  • 其他

第12章 各銷售管道市場

  • 概要
  • 零售藥局
  • 醫院內藥局
  • 藥妝店
  • 線上藥局
  • 其他

第13章 各地區市場

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 瑞士
    • 荷蘭
    • 比利時
    • 丹麥
    • 俄羅斯
    • 瑞典
    • 土耳其
    • 波蘭
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 新加坡
    • 印尼
    • 馬來西亞
    • 紐西蘭
    • 越南
    • 菲律賓
    • 其他亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿曼
    • 其他中東、非洲

第14章 企業形勢

  • 企業佔有率分析: 世界
  • 企業佔有率分析: 北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第15章 企業簡介

  • ABBOTT
  • BIOMARIN
  • MEAD JOHNSON & COMPANY, LLC. (A SUBSIDIARY OF RECKITT BENCKISER GROUP PLC.)
  • NESTLE HEALTH SCIENCE (A SUBSIDIARY OF NESTLE)
  • AJINOMOTO CAMBROOKE, INC. (A SUBSIDIARY OF AJINOMOTO CO., INC.)
  • APR
  • DR. SCHAR AG / SPA
  • ENER-G FOODS, INC.
  • NUTRICIA (A SUBSIDIARY OF DANONE)
  • PKU-MDMIL
  • POA PHARMA
  • PRISTINE ORGANICS PRIVATE LIMITED
  • PROMIN METABOLICS
  • SOLACE NUTRITION

第16章 SWOT和DBMR的市場調查分析

  • SWOT分析
    • 優勢:-強力的產品系列
    • 弱點:-無擴張舉措
    • 市場機會:- 調查開發的投資增加
    • 威脅:-激烈的競爭
  • DBMR市場調查分析

第17章 結論

第18章 問卷調查

第19章 相關報告

目錄

Global medical foods for inborn errors of metabolism is projected to register a CAGR of 12.3% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation

Global Medical Foods For Inborn Errors of Metabolism Market, By Products (Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula With Iron, Low Protein Food and Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Tyrosinemia Types I And II, Urea Cycle Disorders and Others), Forms (Powder, Liquids, gels and Others) Packaging (Can, Jar, Packets, Bottle and Others), Distribution Channel (Retail Pharmacies , Hospital Pharmacies, Drugs Stores, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Poland, Denmark Belgium, Russia, Turkey and rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, Oman and rest of Middle East and Africa) Industry Trends & Forecast to 2020

Some of the major factors contributing to the growth of the global medical foods for inborn errors of metabolism market are:

Increase in the incidence of inborn error of metabolism

Preference of dietary supplements over enzyme replacement therapy

Government initiatives and programs for creating awareness about IEM

Market Players

The key market players for global medical foods for inborn errors of metabolism market are listed below:

Nestle Health Science (A subsidiary of Nestle)

Nutricia (A subsidiary of Danone)

Solace Nutrition, Abbott

Mead Johnson & Company, LLC (A subsidiary of Reckitt Benckiser)

BioMarin Pharmaceutical, Ajinomoto Cambrooke, Inc. (A subsidiary of Ajinomoto)

Poa Pharma

PKU-MDmil

Dr.Schar AG/SPA

Primus Pharmaceuticals, Inc

Pristine Organics Pvt. Ltd

APR

Ener-G foods, INC

Promin Metabolics

TABLE OF CONTENTS

1 INTRODUCTION 40

  • 1.1 OBJECTIVES OF THE STUDY 40
  • 1.2 MARKET DEFINITION 40
  • 1.3 OVERVIEW OF GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET 40
  • 1.4 CURRENCY AND PRICING 42
  • 1.5 LIMITATIONS 42
  • 1.6 MARKETS COVERED 42

2 MARKET SEGMENTATION 46

  • 2.1 MARKETS COVERED 46
  • 2.2 GEOGRAPHICAL SCOPE 47
  • 2.3 YEARS CONSIDERED FOR THE STUDY 48
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 49
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 52
  • 2.6 MULTIVARIATE MODELLING 53
  • 2.7 PRODUCTS LIFELINE CURVE 53
  • 2.8 DBMR MARKET POSITION GRID 54
  • 2.9 SECONDARY SOURCES 56
  • 2.10 ASSUMPTIONS 56

3 EXECUTIVE SUMMARY 57

4 PREMIUM INSIGHTS 60

  • 4.1 CLINICAL TRIALS 63
  • 4.2 RECENT DEVELOPMENTS 63
  • 4.3 BRAND COMPETITIVE ANALYSIS 63
  • 4.4 SUPPLY CHAIN ANALYSIS 64

5 MARKET OVERVIEW 65

  • 5.1 DRIVERS 67
    • 5.1.1 RISING INCIDENCES OF INBORN ERRORS OF METABOLISM 67
    • 5.1.2 PREFERENCE OF DIETARY SUPPLEMENTS OVER ENZYME REPLACEMENT THERAPY 67
    • 5.1.3 GOVERNMENT INITIATIVES AND PROGRAMS FOR CREATING AWARENESS ABOUT IEM 68
    • 5.1.4 INCREASE IN THE NUMBER OF NEW BORN SCREENING PROCEDURES 68
  • 5.2 RESTRAINTS 69
    • 5.2.1 INADEQUATE REIMBURSEMENT SCENARIO 69
    • 5.2.2 STRINGENT REGULATIONS FOR MEDICAL FOODS 69
    • 5.2.3 HIGH COST OF MEDICAL FOODS 70

  • 5.3 OPPORTUNITIES 71
    • 5.3.1 INNOVATIVE PRODUCT LAUNCHES FOR NEW INDICATIONS 71
    • 5.3.2 INCREASING SPENDING ON MEDICAL FOODS PRODUCTS 71
  • 5.4 CHALLENGES 73
    • 5.4.1 PRODUCT RECALLS 73
    • 5.4.2 POOR ACCESSIBILITY OF MEDICAL FOODS 73

6 COVID-19 IMPACT ANALYSIS 74

7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS 75

  • 7.1 OVERVIEW 76
  • 7.2 AMINO ACID 77
    • 7.2.1 SINGLE AMINO ACID 78
      • 7.2.1.1 L-ARGININE 79
      • 7.2.1.2 L-ISOLEUCINE 79
      • 7.2.1.3 L-TYROSINE 79
      • 7.2.1.4 L-LEUCINE 79
      • 7.2.1.5 GLYCINE 79
      • 7.2.1.6 OTHERS 79
    • 7.2.2 AMINO ACID MIXTURES 80
      • 7.2.2.1 PHENYLADE 80
        • 7.2.2.1.1 DRINK MIX 81
        • 7.2.2.1.2 GMP MIX-IN 81
        • 7.2.2.1.3 GMP READY 81
        • 7.2.2.1.4 OTHERS 81
      • 7.2.2.2 PERIFLEX 81
      • 7.2.2.3 LOPHLEX 81
      • 7.2.2.4 PHLEXY 81
      • 7.2.2.5 COOLER 81
      • 7.2.2.6 ANAMIX 81
      • 7.2.2.7 LYSINE-FREE, LOW TRYPTOPHAN 82
      • 7.2.2.8 GLUTARADE ESSENTIAL GA-1 82
      • 7.2.2.9 GLUTARADE GA-1 AMINO ACID BLEND 82
      • 7.2.2.10 GLYTACTIN WITH GMP 82
      • 7.2.2.11 OTHERS 82
  • 7.3 LOW PROTEIN FOOD 82
  • 7.4 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON 83
  • 7.5 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON 84
  • 7.6 OTHERS 85

8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP 86

  • 8.1 OVERVIEW 87
  • 8.2 INFANTS 88
  • 8.3 WEANING 88
  • 8.4 ADOLESCENT 89
  • 8.5 ADULTS 90

9 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES 91

  • 9.1 OVERVIEW 92
  • 9.2 PHENYLKETONURIA (PKU) 93
    • 9.2.1 PHENYLADE 94
    • 9.2.2 PERIFLEX 94
    • 9.2.3 LOPHLEX 94
    • 9.2.4 OTHERS 94
  • 9.3 TYROSINEMIA TYPES I AND II 95
  • 9.4 MAPLE SYRUP URINE DISEASE (MSUD) 95
    • 9.4.1 ANAMIX 96
    • 9.4.2 COOLER 97
    • 9.4.3 MSUD GEL 97
    • 9.4.4 AMINO ACID BLEND 97
    • 9.4.5 MAXMUM 97
    • 9.4.6 OTHERS 97
  • 9.5 HOMOCYSTINURIA 97
  • 9.6 GLUTARIC ACIDEMIA TYPE I 98
  • 9.7 UREA CYCLE DISORDERS 99
  • 9.8 METHYLMALONIC ACIDEMIA 99
  • 9.9 ISOVALERIC ACIDEMIA 100
  • 9.10 ORGANIC ACIDURIAS 101
  • 9.11 RENAL DISEASE 102
  • 9.12 PROPIONIC ACIDEMIA 102
  • 9.13 DISORDERS OF LEUCINE METABOLISM 103
  • 9.14 OTHERS 104

10 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM 105

  • 10.1 OVERVIEW 106
  • 10.2 POWDER 107
  • 10.3 LIQUID 107
  • 10.4 OTHERS 108

11 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING 109

  • 11.1 OVERVIEW 110
  • 11.2 CAN 111
  • 11.3 PACKET 111
  • 11.4 BOTTLE 112
  • 11.5 JAR 113
  • 11.6 OTHERS 114

12 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL 115

  • 12.1 OVERVIEW 116
  • 12.2 RETAIL PHARMACIES 117
  • 12.3 HOSPITAL PHARMACIES 117
  • 12.4 DRUGS STORES 118
  • 12.5 ONLINE PHARMACIES 119
  • 12.6 OTHERS 119

13 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION 121

  • 13.1 OVERVIEW 122
  • 13.2 NORTH AMERICA 127
    • 13.2.1 U.S. 135
    • 13.2.2 CANADA 140
    • 13.2.3 MEXICO 145
  • 13.3 EUROPE 150
    • 13.3.1 GERMANY 158
    • 13.3.2 FRANCE 163
    • 13.3.3 U.K. 168
    • 13.3.4 ITALY 173
    • 13.3.5 SPAIN 178
    • 13.3.6 SWITZERLAND 183
    • 13.3.7 NETHERLANDS 188
    • 13.3.8 BELGIUM 193
    • 13.3.9 DENMARK 198
    • 13.3.10 RUSSIA 203
    • 13.3.11 SWEDEN 208
    • 13.3.12 TURKEY 213
    • 13.3.13 POLAND 218
    • 13.3.14 REST OF EUROPE 223
  • 13.4 ASIA-PACIFIC 224
    • 13.4.1 CHINA 232
    • 13.4.2 JAPAN 237
    • 13.4.3 INDIA 242
    • 13.4.4 AUSTRALIA 247
    • 13.4.5 SOUTH KOREA 252
    • 13.4.6 THAILAND 257
    • 13.4.7 SINGAPORE 262
    • 13.4.8 INDONESIA 267
    • 13.4.9 MALAYSIA 272
    • 13.4.10 NEW ZEALAND 277
    • 13.4.11 VIETNAM 282
    • 13.4.12 PHILIPPINES 287
    • 13.4.13 REST OF ASIA-PACIFIC 292
  • 13.5 SOUTH AMERICA 293
    • 13.5.1 BRAZIL 301
    • 13.5.2 ARGENTINA 306
    • 13.5.3 REST OF SOUTH AMERICA 311
  • 13.6 MIDDLE EAST & AFRICA 312
    • 13.6.1 SOUTH AFRICA 320
    • 13.6.2 SAUDI ARABIA 325
    • 13.6.3 OMAN 330
    • 13.6.4 REST OF MIDDLE EAST & AFRICA 335

14 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, COMPANY LANDSCAPE 336

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL 336
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 337
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE 338
  • 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 339

15 COMPANY PROFILE 340

  • 15.1 ABBOTT 340
    • 15.1.1 COMPANY SNAPSHOT 340
    • 15.1.2 REVENUE ANALYSIS 341
    • 15.1.3 COMPANY SHARE ANALYSIS 341
    • 15.1.4 PRODUCT PORTFOLIO 342
    • 15.1.5 RECENT DEVELOPMENT 342
  • 15.2 BIOMARIN 343
    • 15.2.1 COMPANY SNAPSHOT 343
    • 15.2.2 REVENUE ANALYSIS 343
    • 15.2.3 COMPANY SHARE ANALYSIS 344
    • 15.2.4 PRODUCT PORTFOLIO 344
    • 15.2.5 RECENT DEVELOPMENT 344
  • 15.3 MEAD JOHNSON & COMPANY, LLC. (A SUBSIDIARY OF RECKITT BENCKISER GROUP PLC.) 345
    • 15.3.1 COMPANY SNAPSHOT 345
    • 15.3.2 REVENUE ANALYSIS 346
    • 15.3.3 COMPANY SHARE ANALYSIS 346
    • 15.3.4 PRODUCT PORTFOLIO 347
    • 15.3.5 RECENT DEVELOPMENT 347
  • 15.4 NESTLE HEALTH SCIENCE (A SUBSIDIARY OF NESTLE) 348
    • 15.4.1 COMPANY SNAPSHOT 348
    • 15.4.2 REVENUE ANALYSIS 348
    • 15.4.3 COMPANY SHARE ANALYSIS 349
    • 15.4.4 PRODUCT PORTFOLIO 349
    • 15.4.5 RECENT DEVELOPMENT 350
  • 15.5 AJINOMOTO CAMBROOKE, INC. (A SUBSIDIARY OF AJINOMOTO CO., INC.) 351
    • 15.5.1 COMPANY SNAPSHOT 351
    • 15.5.2 REVENUE ANALYSIS 351
    • 15.5.3 PRODUCT PORTFOLIO 352
    • 15.5.4 RECENT DEVELOPMENTS 353
  • 15.6 APR 354
    • 15.6.1 COMPANY SNAPSHOT 354
    • 15.6.2 PRODUCT PORTFOLIO 354
    • 15.6.3 RECENT DEVELOPMENT 354
  • 15.7 DR. SCHAR AG / SPA 355
    • 15.7.1 COMPANY SNAPSHOT 355
    • 15.7.2 PRODUCT PORTFOLIO 355
    • 15.7.3 RECENT DEVELOPMENT 356

  • 15.8 ENER-G FOODS, INC. 357
    • 15.8.1 COMPANY SNAPSHOT 357
    • 15.8.2 PRODUCT PORTFOLIO 357
    • 15.8.3 RECENT DEVELOPMENT 357
  • 15.9 NUTRICIA (A SUBSIDIARY OF DANONE) 358
    • 15.9.1 COMPANY SNAPSHOT 358
    • 15.9.2 REVENUE ANALYSIS 358
    • 15.9.3 PRODUCT PORTFOLIO 359
    • 15.9.4 RECENT DEVELOPMENT 361
  • 15.10 PKU-MDMIL 362
    • 15.10.1 COMPANY SNAPSHOT 362
    • 15.10.2 PRODUCT PORTFOLIO 362
    • 15.10.3 RECENT DEVELOPMENT 362
  • 15.11 POA PHARMA 363
    • 15.11.1 COMPANY SNAPSHOT 363
    • 15.11.2 PRODUCT PORTFOLIO 363
    • 15.11.3 RECENT DEVELOPMENTS 363
  • 15.12 PRISTINE ORGANICS PRIVATE LIMITED 364
    • 15.12.1 COMPANY SNAPSHOT 364
    • 15.12.2 PRODUCT PORTFOLIO 364
    • 15.12.3 RECENT DEVELOPMENT 365
  • 15.13 PROMIN METABOLICS 366
    • 15.13.1 COMPANY SNAPSHOT 366
    • 15.13.2 PRODUCT PORTFOLIO 366
    • 15.13.3 RECENT DEVELOPMENT 366
  • 15.14 SOLACE NUTRITION 367
    • 15.14.1 COMPANY SNAPSHOT 367
    • 15.14.2 PRODUCT PORTFOLIO 367
    • 15.14.3 RECENT DEVELOPMENT 367

16 SWOT & DATA BRIDGE MARKET RESEARCH ANALYSIS 368

  • 16.1 SWOT ANALYSIS 368
    • 16.1.1 STRENGTH: - STRONG PRODUCT PORTFOLIO 368
    • 16.1.2 WEAKNESS: - NO INITIATIVES FOR EXPANSION 368
    • 16.1.3 OPPORTUNITY: - INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT 368
    • 16.1.4 THREAT: - STIFF COMPETITION 369
  • 16.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 369

17 CONCLUSION 370

18 QUESTIONNAIRE 371

19 RELATED REPORTS 374

LIST OF TABLES

  • TABLE 1 COSTS OF MEDICAL FOODS
  • TABLE 2 ESTIMATED COSTS PER YEAR FOR MEDICAL FOODS FOR IEM, BY SELECTED AGE GROUP
  • TABLE 3 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL LOW PROTEIN FOODS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 GLOBAL ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 GLOBAL ADULT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 19 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 21 GLOBAL TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23 GLOBAL MAPLE SYRUP URINE DISEASE(MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 24 GLOBAL HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 GLOBAL GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 27 GLOBAL METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28 GLOBAL ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29 GLOBAL ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30 GLOBAL RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31 GLOBAL PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32 GLOBAL DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 33 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 35 GLOBAL POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 36 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 37 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 38 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 39 GLOBAL CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 40 GLOBAL PACKET IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 41 GLOBAL BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 42 GLOBAL JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 43 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 44 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTON CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 45 GLOBAL RETAIL PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 46 GLOBAL HOSPITAL PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 47 GLOBAL DRUGS STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 48 GLOBAL ONLINE PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 49 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 50 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 51 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 52 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 53 NORTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 54 NORTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 55 NORTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 56 NORTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 57 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 58 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 59 NORTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 60 NORTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 61 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 62 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 63 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 64 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 65 U.S. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 66 U.S. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 67 U.S. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 68 U.S. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 69 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 70 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 71 U.S. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 72 U.S. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 73 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 74 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 75 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 76 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 77 CANADA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 78 CANADA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 79 CANADA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 80 CANADA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 81 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 82 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 83 CANADA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 84 CANADA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 85 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 86 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 87 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 88 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 89 MEXICO AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 90 MEXICO SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 91 MEXICO AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 92 MEXICO PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 93 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 94 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 95 MEXICO PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 96 MEXICO MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 97 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 98 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 99 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 100 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 101 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 102 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 103 EUROPE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 104 EUROPE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 105 EUROPE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 106 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 107 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 108 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 109 EUROPE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 110 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 111 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 112 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 113 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 114 GERMANY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 115 GERMANY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 116 GERMANY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 117 GERMANY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 118 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 119 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 120 GERMANY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 121 GERMANY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 122 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 123 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 124 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 125 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 126 FRANCE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 127 FRANCE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 128 FRANCE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 129 FRANCE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 130 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 131 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 132 FRANCE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 133 FRANCE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 134 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 135 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 136 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 137 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 138 U.K. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 139 U.K. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 140 U.K. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 141 U.K. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 142 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 143 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 144 U.K. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 145 U.K. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 146 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 147 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 148 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 149 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 150 ITALY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 151 ITALY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 152 ITALY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 153 ITALY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 154 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 155 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 156 ITALY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 157 ITALY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 158 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 159 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 160 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 161 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 162 SPAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 163 SPAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 164 SPAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 165 SPAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 166 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 167 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 168 SPAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 169 SPAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 170 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 171 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 172 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 173 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 174 SWITZERLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 175 SWITZERLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 176 SWITZERLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 177 SWITZERLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 178 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 179 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 180 SWITZERLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 181 SWITZERLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 182 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 183 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 184 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 185 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 186 NETHERLANDS AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 187 NETHERLANDS SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 188 NETHERLANDS AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 189 NETHERLANDS PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 190 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 191 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 192 NETHERLANDS PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 193 NETHERLANDS MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 194 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 195 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 196 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 197 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 198 BELGIUM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 199 BELGIUM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 200 BELGIUM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 201 BELGIUM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 202 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 203 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 204 BELGIUM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 205 BELGIUM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 206 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 207 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 208 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 209 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 210 DENMARK AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 211 DENMARK SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 212 DENMARK AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 213 DENMARK PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 214 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 215 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 216 DENMARK PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 217 DENMARK MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 218 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 219 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 220 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 221 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 222 RUSSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 223 RUSSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 224 RUSSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 225 RUSSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 226 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 227 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 228 RUSSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 229 RUSSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 230 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 231 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 232 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 233 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 234 SWEDEN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 235 SWEDEN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 236 SWEDEN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 237 SWEDEN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 238 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 239 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 240 SWEDEN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 241 SWEDEN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 242 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 243 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 244 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 245 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 246 TURKEY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 247 TURKEY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 248 TURKEY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 249 TURKEY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 250 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 251 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 252 TURKEY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 253 TURKEY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 254 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 255 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 256 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 257 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 258 POLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 259 POLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 260 POLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 261 POLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 262 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 263 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 264 POLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 265 POLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 266 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 267 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 268 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 269 REST OF EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 270 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 271 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 272 ASIA-PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 273 ASIA-PACIFIC SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 274 ASIA-PACIFIC AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 275 ASIA-PACIFIC PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 276 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 277 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 278 ASIA-PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 279 ASIA-PACIFIC MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 280 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 281 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 282 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 283 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 284 CHINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 285 CHINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 286 CHINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 287 CHINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 288 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 289 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 290 CHINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 291 CHINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 292 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 293 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 294 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 295 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 296 JAPAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 297 JAPAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 298 JAPAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 299 JAPAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 300 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 301 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 302 JAPAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 303 JAPAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 304 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 305 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 306 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 307 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 308 INDIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 309 INDIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 310 INDIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 311 INDIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 312 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 313 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 314 INDIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 315 INDIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 316 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 317 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 318 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 319 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 320 AUSTRALIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 321 AUSTRALIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 322 AUSTRALIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 323 AUSTRALIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 324 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 325 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 326 AUSTRALIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 327 AUSTRALIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 328 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 329 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 330 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 331 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 332 SOUTH KOREA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 333 SOUTH KOREA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 334 SOUTH KOREA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 335 SOUTH KOREA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 336 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 337 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 338 SOUTH KOREA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 339 SOUTH KOREA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 340 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 341 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 342 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 343 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 344 THAILAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 345 THAILAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 346 THAILAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 347 THAILAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 348 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 349 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 350 THAILAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 351 THAILAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 352 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 353 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 354 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 355 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 356 SINGAPORE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 357 SINGAPORE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 358 SINGAPORE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 359 SINGAPORE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 360 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 361 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 362 SINGAPORE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 363 SINGAPORE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 364 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 365 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 366 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 367 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 368 INDONESIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 369 INDONESIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 370 INDONESIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 371 INDONESIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 372 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 373 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 374 INDONESIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 375 INDONESIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 376 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 377 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 378 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 379 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 380 MALAYSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 381 MALAYSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 382 MALAYSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 383 MALAYSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 384 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 385 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 386 MALAYSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 387 MALAYSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 388 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 389 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 390 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 391 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 392 NEW ZEALAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 393 NEW ZEALAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 394 NEW ZEALAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 395 NEW ZEALAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 396 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 397 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 398 NEW ZEALAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 399 NEW ZEALAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 400 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 401 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 402 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 403 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 404 VIETNAM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 405 VIETNAM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 406 VIETNAM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 407 VIETNAM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 408 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 409 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 410 VIETNAM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 411 VIETNAM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 412 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 413 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 414 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 415 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 416 PHILIPPINES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 417 PHILIPPINES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 418 PHILIPPINES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 419 PHILIPPINES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 420 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 421 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 422 PHILIPPINES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 423 PHILIPPINES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 424 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 425 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 426 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 427 REST OF ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 428 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 429 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 430 SOUTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 431 SOUTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 432 SOUTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 433 SOUTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 434 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 435 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 436 SOUTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 437 SOUTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 438 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 439 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 440 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 441 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 442 BRAZIL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 443 BRAZIL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 444 BRAZIL AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 445 BRAZIL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 446 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 447 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 448 BRAZIL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 449 BRAZIL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 450 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 451 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 452 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 453 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 454 ARGENTINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 455 ARGENTINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 456 ARGENTINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 457 ARGENTINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 458 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 459 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 460 ARGENTINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 461 ARGENTINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 462 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 463 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 464 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 465 REST OF SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 466 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 467 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 468 MIDDLE EAST & AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 469 MIDDLE EAST & AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 470 MIDDLE EAST & AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 471 MIDDLE EAST & AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 472 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 473 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 474 MIDDLE EAST & AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 475 MIDDLE EAST & AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 476 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 477 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 478 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 479 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 480 SOUTH AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 481 SOUTH AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 482 SOUTH AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 483 SOUTH AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 484 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 485 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 486 SOUTH AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 487 SOUTH AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 488 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 489 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 490 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 491 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 492 SAUDI ARABIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 493 SAUDI ARABIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 494 SAUDI ARABIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 495 SAUDI ARABIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 496 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 497 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 498 SAUDI ARABIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 499 SAUDI ARABIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 500 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 501 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 502 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 503 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 504 OMAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 505 OMAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 506 OMAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 507 OMAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 508 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)
  • TABLE 509 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)
  • TABLE 510 OMAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 511 OMAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)
  • TABLE 512 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 513 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)
  • TABLE 514 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 515 REST OF MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION
  • FIGURE 9 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2
  • FIGURE 10 RISE IN THE INCIDENCE OF INBORN ERRORSOF METABOLISM AND PREFERENCE OF DIET THERAPY OVER ENZYME SUBSTITUITION ARE EXPECTED TO DRIVE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET IN THE FORECAST PERIOD OF 2020 TO 2
  • FIGURE 11 AMINO ACID IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET IN 2020 & 2
  • FIGURE 12 ASIA-PACIFIC IS THE MAXIMUM GROWING REGION FOR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2
  • FIGURE 13 VENDOR SHARE ANALYSIS
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET
  • FIGURE 15 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, 2019
  • FIGURE 16 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, 2019
  • FIGURE 17 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, 2019
  • FIGURE 18 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORM, 2019
  • FIGURE 19 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, 2019
  • FIGURE 20 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, 2019
  • FIGURE 21 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2019)
  • FIGURE 22 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY REGION (2019)
  • FIGURE 23 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY REGION (2020 & 2027)
  • FIGURE 24 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY REGION (2019 & 2027)
  • FIGURE 25 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS (2020-2027)
  • FIGURE 26 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2019)
  • FIGURE 27 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019)
  • FIGURE 28 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 29 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 30 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS (2020-2027)
  • FIGURE 31 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2019)
  • FIGURE 32 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019)
  • FIGURE 33 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 34 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 35 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS (2020-2027)
  • FIGURE 36 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2019)
  • FIGURE 37 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019)
  • FIGURE 38 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 39 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 40 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS (2020-2027)
  • FIGURE 41 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2019)
  • FIGURE 42 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019)
  • FIGURE 43 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 44 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 45 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS (2020-2027)
  • FIGURE 46 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2019)
  • FIGURE 47 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019)
  • FIGURE 48 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 49 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 50 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS (2020-2027)
  • FIGURE 51 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 52 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 53 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 54 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2019 (%)